Financial support from the Agence nationale de recherche sur le sida et les hépatites virales (ECTZ158948 to A.B. and ECTZ143165 to M.L.) and the China Scholarship Council (202008620095) is gratefully ...

Republic of Korea # Virus Research and Testing Group, Korea Research Institute of Chemical Technology, Daejeon 305-600, Republic of Korea *S.S.K.: phone, +82-2-961-0524; fax, +82-2-959-8168; e-mail, ...

Not only is the hepatitis B virus responsible for 54% of liver cancer cases, but the Centers for Disease Control and Prevention (CDC) recommends that all adults aged 19-59 get vaccinated against ...

Hepatitis B is a contagious liver infection that's transmitted through blood, semen or another type of bodily fluid from a person who's infected with the virus, according to the CDC. The severity ...

The Coaltion for Global Hepatitis Elimination's National Hepatitis Elimination Profiles assess the status of national data, ...

Vir is holding off on advancing the combination therapy to Phase III trials until it secures a development partner.

A model for hepatitis B virus-associated chronic liver disease has been made using cloned hepatitis B virus DNA as a transgene in a severe combined immunodeficient host. These mice consistently ...

Vir Biotechnology’s sidelined hepatitis B candidate, designed to serve as a “functional cure,” has failed to achieve the efficacy results hoped for in a midstage study. The investigational ...

An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...

More apparent signs of infection, such as yellow eyes, may emerge later—but possibly only after a test for the virus starts showing as negative. Diseases similar to hepatitis A have been ...

Hepatitis is an inflammation of the liver, most commonly caused by a viral infection. The three main types—Hepatitis A, B, and C—pose different risks but can all lead to serious health complications ...